Showing results (1-10 of 199) with videos related to
Sort By:
Pageof 20
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2006
[Idiopathic pulmonary fibrosis (IPF)]Aki Matsumoto, Arata AzumaClinical Immunology (Orlando, Fla.)|September 19, 2006
Repeated exposure to low-dose diesel exhaust after allergen challenge exaggerates asthmatic responses in miceAki Matsumoto, Kumiko Hiramatsu, Yingji Li, et al.Experimental Lung Research|July 11, 2007
Airway inflammatory responses to oxidative stress induced by low-dose diesel exhaust particle exposure differ between mouse strainsYing-Ji Li, Tomoyuki Kawada, Aki Matsumoto, et al.Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|February 7, 2006
[Pneumocystis jiroveci pneumonia as a complication of glucocorticoid therapy for interstitial pneumonia]Tatsuji Enomoto, Arata Azuma, Aki Matsumoto, et al.Expert Review of Respiratory Medicine|June 8, 2010
Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosisArata AzumaTherapeutic Advances in Respiratory Disease|February 16, 2012
Pirfenidone treatment of idiopathic pulmonary fibrosisArata AzumaNihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|March 1, 2005
[Expectation of new treatments for idiopathic interstitial pneumonias]Arata AzumaInternal Medicine (Tokyo, Japan)|January 8, 2008
Preventive effect of sulfamethoxasole-trimethoprim on Pneumocystis jiroveci pneumonia in patients with interstitial pneumoniaTatsuji Enomoto, Arata Azuma, Aki Matsumoto, et al.Modern Rheumatology|November 22, 2019
Nintedanib: New indication for systemic sclerosis-associated interstitial lung diseaseMasataka Kuwana, Arata AzumaTuberculosis and Respiratory Diseases|June 25, 2020
New Era of Management Concept on Pulmonary Fibrosis with Revisiting Framework of Interstitial Lung DiseasesArata Azuma, Luca RicheldiPageof 20